Skip to main content
Top
Published in: Digestive Diseases and Sciences 6/2022

06-06-2021 | Hepatitis C | Original Article

International Classification of Diseases Codes are Useful in Identifying Cirrhosis in Administrative Databases

Authors: Monica Dahiya, Ejemai Eboreime, Ashley Hyde, Sholeh Rahman, Meghan Sebastianski, Michelle Carbonneau, Elliot B. Tapper, Puneeta Tandon

Published in: Digestive Diseases and Sciences | Issue 6/2022

Login to get access

Abstract

Background

Health administrative databases are essential to define patient populations, make socioeconomic predictions, and facilitate medical research and healthcare planning. The accuracy of this data is dependent on valid codes/coding algorithms.

Aims

The aim of this study was to systematically identify and summarize the validity of International Classification of Diseases (ICD) codes for identifying patients with cirrhosis in administrative data.

Methods

Electronic databases, MEDLINE (via Ovid), EMBASE (via Ovid), the Web of Science, and CINAHL (via EBSCOhost), were searched for validation studies which compared ICD codes related to cirrhosis to a clinical reference standard, and reported statistical measures of performance.

Results

Fourteen studies were included in the review. There was a large variation in the algorithms used to validate ICD codes to diagnose cirrhosis. Despite the variation, the positive predictive value (PPV) was greater than 84% and the specificity was greater than 75% in the majority of the studies. The negative predictive value (NPV) was lower, but still was associated with values greater than 70% in the majority of studies. Sensitivity data varied significantly with values ranging from 0.27 to 99%.

Conclusions

Evaluated ICD codes for cirrhosis, including codes for chronic liver disease, cirrhosis-specific codes, and cirrhosis-related complications, have demonstrated variable sensitivity and reasonable specificity for the identification of cirrhosis. Additional research is needed to maximize the identification of persons with cirrhosis to avoid underestimating the burden of disease.
Appendix
Available only for authorised users
Literature
1.
go back to reference Collaborators GBDCoD. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736–1788. Collaborators GBDCoD. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736–1788.
2.
go back to reference Collaborators GBDC. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 2020;5:245–266.CrossRef Collaborators GBDC. The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol 2020;5:245–266.CrossRef
3.
go back to reference Fleming KM, Aithal GP, Card TR et al. All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study. Liver Int 2012;32:79–84.CrossRef Fleming KM, Aithal GP, Card TR et al. All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study. Liver Int 2012;32:79–84.CrossRef
4.
go back to reference Fleming KM, Aithal GP, Card TR et al. The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study. Aliment Pharmacol Ther 2010;32:1343–1350.CrossRef Fleming KM, Aithal GP, Card TR et al. The rate of decompensation and clinical progression of disease in people with cirrhosis: a cohort study. Aliment Pharmacol Ther 2010;32:1343–1350.CrossRef
5.
go back to reference Volk ML, Tocco RS, Bazick J et al. Hospital readmissions among patients with decompensated cirrhosis. Am J Gastroenterol 2012;107:247–252.CrossRef Volk ML, Tocco RS, Bazick J et al. Hospital readmissions among patients with decompensated cirrhosis. Am J Gastroenterol 2012;107:247–252.CrossRef
6.
go back to reference Bajaj JS, Reddy KR, Tandon P et al. The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis. Hepatology 2016;64:200–208.CrossRef Bajaj JS, Reddy KR, Tandon P et al. The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis. Hepatology 2016;64:200–208.CrossRef
7.
go back to reference Estes C, Razavi H, Loomba R et al. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology 2018;67:123–133.CrossRef Estes C, Razavi H, Loomba R et al. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology 2018;67:123–133.CrossRef
8.
go back to reference Harbaugh CM, Cooper JN. Administrative databases. Semin Pediatr Surg 2018;27:353–360.CrossRef Harbaugh CM, Cooper JN. Administrative databases. Semin Pediatr Surg 2018;27:353–360.CrossRef
9.
go back to reference Mokdad AH, Mensah GA, Krish V et al. Global, regional, national, and subnational big data to inform health equity research: perspectives from the Global Burden of Disease Study 2017. Ethnic Dis 2019;29:159–172.CrossRef Mokdad AH, Mensah GA, Krish V et al. Global, regional, national, and subnational big data to inform health equity research: perspectives from the Global Burden of Disease Study 2017. Ethnic Dis 2019;29:159–172.CrossRef
10.
go back to reference Garratt E, Barnes H, Dibben C. Health administrative data: exploring the potential for academic research. St Andrews: Administrative Data Liaison Service. 2010. Garratt E, Barnes H, Dibben C. Health administrative data: exploring the potential for academic research. St Andrews: Administrative Data Liaison Service. 2010.
11.
go back to reference Jutte DP, Roos LL, Brownell MD. Administrative record linkage as a tool for public health research. Ann Rev Public Health 2011;32:91–108.CrossRef Jutte DP, Roos LL, Brownell MD. Administrative record linkage as a tool for public health research. Ann Rev Public Health 2011;32:91–108.CrossRef
12.
go back to reference Abraha I, Orso M, Grilli P et al. The current state of validation of administrative healthcare databases in Italy: a systematic review. Int J Stat Med Res 2014;3:309–320.CrossRef Abraha I, Orso M, Grilli P et al. The current state of validation of administrative healthcare databases in Italy: a systematic review. Int J Stat Med Res 2014;3:309–320.CrossRef
13.
go back to reference Khokhar B, Jette N, Metcalfe A, et al. Systematic review of validated case definitions for diabetes in ICD-9-coded and ICD-10-coded data in adult populations. BMJ Open. 2016;6. Khokhar B, Jette N, Metcalfe A, et al. Systematic review of validated case definitions for diabetes in ICD-9-coded and ICD-10-coded data in adult populations. BMJ Open. 2016;6.
14.
go back to reference Moher D, Liberati A, Tetzlaff J et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann. Internal Med. 2009;151:264–269.CrossRef Moher D, Liberati A, Tetzlaff J et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann. Internal Med. 2009;151:264–269.CrossRef
15.
go back to reference D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006;44:217–231.CrossRef D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 2006;44:217–231.CrossRef
16.
go back to reference Lapointe-Shaw L, Georgie F, Carlone D et al. Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: a validation study. PLoS ONE 2018;13:e0201120.CrossRef Lapointe-Shaw L, Georgie F, Carlone D et al. Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: a validation study. PLoS ONE 2018;13:e0201120.CrossRef
17.
go back to reference D’Amico G, Morabito A, D’Amico M et al. Clinical states of cirrhosis and competing risks. J Hepatol 2018;68:563–576.CrossRef D’Amico G, Morabito A, D’Amico M et al. Clinical states of cirrhosis and competing risks. J Hepatol 2018;68:563–576.CrossRef
18.
go back to reference Benchimol EI, Manuel DG, To T et al. Development and use of reporting guidelines for assessing the quality of validation studies of health administrative data. J Clin Epidemiol 2011;64:821–829.CrossRef Benchimol EI, Manuel DG, To T et al. Development and use of reporting guidelines for assessing the quality of validation studies of health administrative data. J Clin Epidemiol 2011;64:821–829.CrossRef
19.
go back to reference Whiting P, Rutjes AW, Reitsma JB et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003;3:25.CrossRef Whiting P, Rutjes AW, Reitsma JB et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003;3:25.CrossRef
20.
go back to reference Whiting PF, Rutjes AW, Westwood ME et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011;155:529–536.CrossRef Whiting PF, Rutjes AW, Westwood ME et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011;155:529–536.CrossRef
21.
go back to reference Zeng X, Zhang Y, Kwong JS et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med 2015;8:2–10.CrossRef Zeng X, Zhang Y, Kwong JS et al. The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid Based Med 2015;8:2–10.CrossRef
22.
go back to reference Buczinski S, Gicquel E, Fecteau G et al. Systematic review and meta-analysis of diagnostic accuracy of serum refractometry and brix refractometry for the diagnosis of inadequate transfer of passive immunity in calves. J Vet Intern Med 2018;32:474–483.CrossRef Buczinski S, Gicquel E, Fecteau G et al. Systematic review and meta-analysis of diagnostic accuracy of serum refractometry and brix refractometry for the diagnosis of inadequate transfer of passive immunity in calves. J Vet Intern Med 2018;32:474–483.CrossRef
23.
go back to reference Lange B, Roberts T, Cohn J et al. Diagnostic accuracy of detection and quantification of HBV-DNA and HCV-RNA using dried blood spot (DBS) samples—a systematic review and meta-analysis. BMC Infect Dis 2017;17:693.CrossRef Lange B, Roberts T, Cohn J et al. Diagnostic accuracy of detection and quantification of HBV-DNA and HCV-RNA using dried blood spot (DBS) samples—a systematic review and meta-analysis. BMC Infect Dis 2017;17:693.CrossRef
24.
go back to reference Schoots IG, Petrides N, Giganti F et al. Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review. Eur Urol 2015;67:627–636.CrossRef Schoots IG, Petrides N, Giganti F et al. Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review. Eur Urol 2015;67:627–636.CrossRef
25.
go back to reference Brandler ES, Sharma M, Sinert RH et al. Prehospital stroke scales in urban environments: a systematic review. Neurology 2014;82:2241–2249.CrossRef Brandler ES, Sharma M, Sinert RH et al. Prehospital stroke scales in urban environments: a systematic review. Neurology 2014;82:2241–2249.CrossRef
26.
go back to reference Chang E, Yu C, Clarke R et al. Defining a patient population with cirrhosis: an automated algorithm with natural language processing. J Clin Gastroenterol 2016;50:889–894.CrossRef Chang E, Yu C, Clarke R et al. Defining a patient population with cirrhosis: an automated algorithm with natural language processing. J Clin Gastroenterol 2016;50:889–894.CrossRef
27.
go back to reference Goldberg D, Halpern S, Weiner M et al. Validation of three coding algorithms to identify patients with end-stage liver disease in administrative database. Pharmacoepidemiol Drug Saf 2012;21:756–769.CrossRef Goldberg D, Halpern S, Weiner M et al. Validation of three coding algorithms to identify patients with end-stage liver disease in administrative database. Pharmacoepidemiol Drug Saf 2012;21:756–769.CrossRef
28.
go back to reference Kramer J, Davila J, Miller E et al. The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases. Aliment Pharmacol Therap 2008;27:274–282.CrossRef Kramer J, Davila J, Miller E et al. The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases. Aliment Pharmacol Therap 2008;27:274–282.CrossRef
29.
go back to reference Rakoski M, McCammon R, Piette J et al. Burden of cirrhosis on older americans and their families: analysis of the health and retirement study. Hepatology 2012;55:184–191.CrossRef Rakoski M, McCammon R, Piette J et al. Burden of cirrhosis on older americans and their families: analysis of the health and retirement study. Hepatology 2012;55:184–191.CrossRef
30.
go back to reference Shim K. Trends of mortality from liver cirrhosis and its associated characteristics in Allegheny County, Pennsylvania, 1973–1985. 1991. Shim K. Trends of mortality from liver cirrhosis and its associated characteristics in Allegheny County, Pennsylvania, 1973–1985. 1991.
31.
go back to reference Mapkashi S, Kramer J, Richardson P et al. Positive predictive values of internal classification of diseases, 10th revision, codes for cirrhosis and its related complications. Clin Gastroenterol Hepatol 2018;16:1677–1678.CrossRef Mapkashi S, Kramer J, Richardson P et al. Positive predictive values of internal classification of diseases, 10th revision, codes for cirrhosis and its related complications. Clin Gastroenterol Hepatol 2018;16:1677–1678.CrossRef
32.
go back to reference Ramrakhiani N, LE M, Yeo Y, et al. Validity of international classification of diseases, tenth revision, codes for cirrhosis. Digest Dis. 2020. Ramrakhiani N, LE M, Yeo Y, et al. Validity of international classification of diseases, tenth revision, codes for cirrhosis. Digest Dis. 2020.
33.
go back to reference Nehra M, Ma Y, Clark C, et al. Use of administrative claims data for identifying patients with cirrhosis. J Clin Gastroenterol 2013;47. Nehra M, Ma Y, Clark C, et al. Use of administrative claims data for identifying patients with cirrhosis. J Clin Gastroenterol 2013;47.
34.
go back to reference Lo R, Lim J, Bidwell Goetz M et al. Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study. Pharmacoepidemiol Drug Saf 2011;20:289–299. Lo R, Lim J, Bidwell Goetz M et al. Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study. Pharmacoepidemiol Drug Saf 2011;20:289–299.
35.
go back to reference Blake J, Compton K, Schmidt W et al. Accuracy of death certificates in the diagnosis of alcoholic liver cirrhosis. Alcoholism Clin Exp Res 1988;12:168–172.CrossRef Blake J, Compton K, Schmidt W et al. Accuracy of death certificates in the diagnosis of alcoholic liver cirrhosis. Alcoholism Clin Exp Res 1988;12:168–172.CrossRef
36.
go back to reference Hayward K, Johnson A, Mckillen B, et al. ICD-10-AM codes for cirrhosis and related complications: key performance considerations for population and healthcare studies. BMJ Open Gastroenterol. 2020;7. Hayward K, Johnson A, Mckillen B, et al. ICD-10-AM codes for cirrhosis and related complications: key performance considerations for population and healthcare studies. BMJ Open Gastroenterol. 2020;7.
37.
go back to reference Driver R, Balachandrakumar V, Burton A, et al. Validation of an algorithm using inpatient electronic health records to determine the presence and severity of cirrhosis in patients with hepatocellular carcinoma in England: an observational study. BMJ Open 2019;9. Driver R, Balachandrakumar V, Burton A, et al. Validation of an algorithm using inpatient electronic health records to determine the presence and severity of cirrhosis in patients with hepatocellular carcinoma in England: an observational study. BMJ Open 2019;9.
38.
go back to reference Bengtsson B, Askling J, Ludvigsson J et al. Validity of administrative codes associated with cirrhosis in Sweden. Scand J Gastroenterol 2020;55:1205–1210.CrossRef Bengtsson B, Askling J, Ludvigsson J et al. Validity of administrative codes associated with cirrhosis in Sweden. Scand J Gastroenterol 2020;55:1205–1210.CrossRef
39.
go back to reference McCormick N, Lacaille D, Bhole V, et al. Validity of heart failure diagnoses in administrative databases: a systematic review and meta-analysis. PLOS ONE 2014;9. McCormick N, Lacaille D, Bhole V, et al. Validity of heart failure diagnoses in administrative databases: a systematic review and meta-analysis. PLOS ONE 2014;9.
40.
go back to reference Fiest K, Jette N, Quan H, et al. Systematic review and assessment of validated case definitions for depression in administrative data. BMC Psychiatry. 2014;14. Fiest K, Jette N, Quan H, et al. Systematic review and assessment of validated case definitions for depression in administrative data. BMC Psychiatry. 2014;14.
Metadata
Title
International Classification of Diseases Codes are Useful in Identifying Cirrhosis in Administrative Databases
Authors
Monica Dahiya
Ejemai Eboreime
Ashley Hyde
Sholeh Rahman
Meghan Sebastianski
Michelle Carbonneau
Elliot B. Tapper
Puneeta Tandon
Publication date
06-06-2021
Publisher
Springer US
Keyword
Hepatitis C
Published in
Digestive Diseases and Sciences / Issue 6/2022
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-021-07076-1

Other articles of this Issue 6/2022

Digestive Diseases and Sciences 6/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.